Integer (ITGR) Expected to Announce Quarterly Earnings on Thursday

Integer (NYSE:ITGR - Get Free Report) is anticipated to release its Q2 2025 earnings data before the market opens on Thursday, July 24th. Analysts expect Integer to post earnings of $1.57 per share and revenue of $464.37 million for the quarter. Integer has set its FY 2025 guidance at 6.150-6.510 EPS.

Integer (NYSE:ITGR - Get Free Report) last issued its quarterly earnings data on Thursday, April 24th. The medical equipment provider reported $1.31 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.27 by $0.04. The firm had revenue of $437.39 million during the quarter, compared to analysts' expectations of $428.51 million. Integer had a net margin of 4.38% and a return on equity of 11.95%. The business's revenue for the quarter was up 7.3% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.14 earnings per share. On average, analysts expect Integer to post $6 EPS for the current fiscal year and $7 EPS for the next fiscal year.

Integer Trading Down 1.9%

NYSE ITGR traded down $2.13 during trading on Friday, reaching $112.51. 462,592 shares of the stock traded hands, compared to its average volume of 390,126. The firm has a market cap of $3.93 billion, a price-to-earnings ratio of 53.32, a price-to-earnings-growth ratio of 1.01 and a beta of 0.98. The stock's 50-day moving average price is $119.76 and its 200 day moving average price is $124.59. The company has a quick ratio of 2.14, a current ratio of 3.40 and a debt-to-equity ratio of 0.78. Integer has a fifty-two week low of $104.93 and a fifty-two week high of $146.36.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on ITGR. KeyCorp decreased their price objective on shares of Integer from $154.00 to $145.00 and set an "overweight" rating for the company in a report on Monday, April 21st. Wall Street Zen upgraded shares of Integer from a "sell" rating to a "hold" rating in a report on Monday, May 19th. Truist Financial set a $150.00 price objective on shares of Integer and gave the company a "buy" rating in a report on Friday, April 25th. Citigroup upgraded shares of Integer from a "hold" rating to a "strong-buy" rating and upped their price target for the company from $133.00 to $140.00 in a report on Thursday, May 22nd. Finally, Benchmark reduced their price target on shares of Integer from $150.00 to $140.00 and set a "buy" rating for the company in a report on Friday, April 25th. Two investment analysts have rated the stock with a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $146.25.

Insider Buying and Selling

In related news, CEO Joseph W. Dziedzic sold 338,975 shares of the stock in a transaction on Thursday, May 1st. The shares were sold at an average price of $123.17, for a total transaction of $41,751,550.75. Following the completion of the transaction, the chief executive officer owned 47,000 shares in the company, valued at approximately $5,788,990. This represents a 87.82% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Martin C. Maxwell sold 8,720 shares of the stock in a transaction on Thursday, June 5th. The stock was sold at an average price of $120.56, for a total transaction of $1,051,283.20. Following the transaction, the director owned 22,170 shares of the company's stock, valued at $2,672,815.20. The trade was a 28.23% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 362,434 shares of company stock worth $44,577,115. 2.16% of the stock is owned by insiders.

Institutional Trading of Integer

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Millennium Management LLC raised its position in Integer by 2,408.8% during the first quarter. Millennium Management LLC now owns 123,132 shares of the medical equipment provider's stock worth $14,531,000 after acquiring an additional 118,224 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its position in shares of Integer by 4.7% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 109,316 shares of the medical equipment provider's stock valued at $12,900,000 after purchasing an additional 4,873 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in shares of Integer by 4.0% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 21,515 shares of the medical equipment provider's stock valued at $2,539,000 after purchasing an additional 837 shares during the period. Jones Financial Companies Lllp raised its position in shares of Integer by 79,888.9% in the first quarter. Jones Financial Companies Lllp now owns 7,199 shares of the medical equipment provider's stock valued at $850,000 after purchasing an additional 7,190 shares during the period. Finally, United Services Automobile Association bought a new position in shares of Integer in the first quarter valued at about $258,000. 99.29% of the stock is owned by institutional investors.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.